Corporate Social Responsibility in the pharmaceutical industry

Abraham, J. (2002). The pharmaceutical industry as a political player. The Lancet,360(9344), 1498-1502. https://doi.org/10.1016/s0140-6736(02)11477-2

Ahen, F. (2017). Responsibilization and MNC-stakeholder engagement: Who engages whom in the pharmaceutical industry? In R. E. Freeman, J. Kuhala, & S. Sachs (Eds.), Stakeholder engagement: Clinical research cases. (Vol. 46, pp. 87-112). Springer. https://doi.org/10.1007/978-3-319-62785-4_5

Álvarez, C., & Urbano, D. (2011). Una década de investigación basada en el GEM: Logros y retos (A decade of GEM research: Achievements and challenges). Academia Revista Latinoamericana de Administración (46), 16-37. https://ssrn.com/abstract=1801167

Becchetti, L., Ciciretti, R., Hasan, I., & Kobeissi, N. (2012). Corporate social responsibility and shareholder’s value. Journal of Business Research, 65(11), 1628-1635. https://doi.org/10.1016/j.jbusres.2011.10.022

Benn, S., Todd, L., & Pendleton, J. (2010). Public relations leadership in corporate social responsibility. Journal of Business Ethics, 96(3), 403-423. https://doi.org/10.1007/s10551-010-0474-5

Boulouta, I., & Pitelis, C. N. (2014). Who needs CSR? The impact of corporate social responsibility on national competitiveness. Journal of Business Ethics, 119(3), 349-364. https://doi.org/10.1007/s10551-013-1633-2

Bowen, H. R. (1953). Social responsibilities of the businessman (1st ed.). Harper & Brothers.Carroll, A. B. (1979). A three-dimensional conceptual model of corporate performance. Academy of Management Review, 4(4), 497-505. https://doi.org/10.2307/257850

Class, J. (2012). Emerging markets and differential pricing policies: A question of global health? Journal of Commercial Biotechnology 18(4), 40-43.

Chan, W.; Cheah, J., & Montanheiro, L. (2016). Corporate social responsibility in the pharmaceutical industry. In A. Örtenblad (Ed.), Research handbook on corporate social responsibility in context. (1st ed., pp. 175-204). Edward Elgar Publishing Limited. https://doi.org/10.4337/9781783474806

Cheah, E. T., Chan, W. L., & Chieng, C. L. L. (2007). The corporate social responsibility of pharmaceutical product recalls: An empirical examination of U.S. and U.K. markets. Journal of Business Ethics, 76(4), 427-449. https://doi.org/10.1007/s10551-006-9292-1

Commission des Communautés Européennes (C.C.E.) (2001). Livre vert.Protnotivoir un cadre eut opeen pour la responsabilité sociale des enterprises. https://europarl.europa.eu/meetdocs/committees/deve/20020122/com(2001)366_fr.pdf

Coombs, W., & Holladay, S. (2012). Managing corporate social responsibility: A communication approach (1st ed.). Wiley-Blackwell.

Cook, L., LaVan, H., & Zilic, I. (2018). An exploratory analysis of corporate social responsibility reporting in U.S. pharmaceutical companies. Journal of Communication Management, 22(2), 197-211. https://doi.org/10.1108/JCOM-02-2017-0020

Crommelin, D., Stolk, P., Besancon, L., Shah, V., Midha, K., & Leufkens, H. (2010). Pharmaceutical sciences in 2020. Nature Reviews Drug Discovery, 9, 99-100. https://doi.org/10.1038/nrd3087

Davis, K. (1967). Understanding the social responsibility puzzle. Business Horizons,10(4), 45-51. https://doi.org/10.1016/0007-6813(67)90007-9

Demir, M., & Min, M. (2019). Consistencies and discrepancies in corporate social responsibility reporting in the pharmaceutical industry. Sustainability Accounting. Management and Policy Journal, 10(2), 333-364. https://doi.org/10.1108/SAMPJ-03-2018-0094

Duque, Y., Cardona, M., & Rendón, J. (2013). Responsabilidad social empresarial: Teorías, índices, estándares y certificaciones. Cuadernos de Administración-Universidad del Valle, 29(50), 196-206. http://www.redalyc.org/articulo.oa?id=225029797009

Egri, C. P., & Ralston, D. A. (2008). Corporate responsibility: A review of international management research from 1998 to 2007. Journal of International Management, 14(4), 319-339. https://doi.org/10.1016/j.intman.2007.09.003

Elms, H., Berman, S., & Wicks, A. (2002). Ethics and incentives: An evaluation and development of stakeholder theory in the health care industry. Business Ethics Quarterly, 12(4), 413-432. https://doi.org/10.2307/3857993

Emanuel, E. J., Wendler, D., Killen, J., & Grady, C. (2004). What makes clinical research in developing countries ethical? The benchmarks of ethical research. The Journal of Infectious Diseases, 189(5), 930–937. https://doi.org/10.1086/381709

Finegold, D.L., Bensimon, C.M., Daar, A.S., Eaton, M.L., Godard, B., Knoppers, B.M., Mackie, J.E., & Singer, P.A. (2005). BioIndustry Ethics (1st ed.). Elsevier Academic Press.

Frederick, W. (1960). The growing concern over business responsibility. California Management Review, 2(4), 54-61. https://doi.org/10.2307%2F41165405

Friedman, M., (1970, September 13). The social responsibility of business is to increase its profits. The New York Times Magazine, 1-6.

Fort, T. (2014). The paradox of pharmaceutical CSR: The sincerity nexus. Business Horizons, 57(2), 151-160. https://doi.org/10.1016/j.bushor.2013.10.006

Gallagher, J. A., & Goodstein, J. (2002). Fulfilling institutional responsibilities in health care: Organizational ethics and the role of mission discernment. Business Ethics Quarterly, 12(4), 433. https://doi.org/10.2307/3857994

Gambardella, A. (1995). Science and innovation: The US pharmaceutical industry during the 1980s (1st ed.). Cambridge University Press.

Ghormley, E. & Falconi, T. (2010). Communicating responsibility: Capstone research (prepared for NYU M.S. in PR & CC). https://silo.tips/download/communicating-responsibility-capstone-research-prepared-for-nyu-ms-in-pr-cc

Givel, M. (2013). Modern neoliberal philanthropy: motivations and impact of Pfizer Pharmaceutical’s corporate social responsibility campaign. Third World Quarterly,34(1), 171-182. https://doi.org/10.1080/01436597.2012.755013

Goldacre, B. (2012). Bad pharma: How drug companies mislead doctors and harm patients(1st ed.). Fourth Estate.

Görpe, S., & Oksuz, B. (2016a). Corporate social responsibility in the Turkish pharmaceutical industry. In A. Örtenblad (Ed.), Research handbook on corporate social responsibility in context. (1st ed., pp. 251-269). Edward Elgar Publishing Limited. https://doi.org/10.4337/9781783474806

Görpe, S., & Oksuz, B. (2016b). Corporate social responsibility as concept and activity: an overview. In A. Örtenblad (Ed.), Research handbook on corporate social responsibility in context. (1st ed., pp. 17-31). Edward Elgar Publishing Limited. https://doi.org/10.4337/9781783474806

Guthey, E., & Morsing, M. (2013). CSR and the mediated emergence of strategic ambiguity. Journal of Business Ethics, 120(4), 555-569. https://doi.org/10.1007/s10551-013-2005-7

Hansen, SO. (1982). Studies in internationalisation of the pharmaceuticals industry – A taxonomic approach. [Doctoral thesis]. Åbo Akademi University.

Iñesta, A., & Oteo, L. (2011). The pharmaceutical industry and the sustainability of healthcare systems in developed countries and in Latin America. Ciência & Saúde Coletiva, 16(6), 2713-2724. https://doi.org/10.1590/s1413-81232011000600010

International Organization for Standarization (2010). Guidance on social responsibility (ISO 26000:2010). https://www.iso.org/obp/ui#iso:std:iso:26000:ed-1:v1:es

Khaleel, M., Chelliah, S., Rauf, S., & Jamil, M. (2017). Impact of perceived corporate social responsibility on attitudes and behaviors of pharmacists working in MNCs. Humanomics, 33(4), 453-469. https://doi.org/10.1108/H-10-2016-0080

Kolk, A. (2016). The social responsibility of international business: From ethics and the environment to CSR and sustainable development. Journal of World Business, 51(1), 23-34. https://doi.org/10.1016/j.jwb.2015.08.010

Leisinger, K. M. (2009). Corporate responsibilities for access to medicines. Journal of Business Ethics, 85(S1), 3-23. https://doi.org/10.1007/s10551-008-9944-4

Leisinger, K. M. (2005). The corporate social responsibility of the pharmaceutical industry: Idealism without illusion and realism without resignation. Business Ethics Quarterly. 15(4), 577-594. https://doi.org/10.5840/beq200515440

Mehralian, G., Nazari, J. A., Zarei, L., & Rasekh, H. R. (2016). The effects of corporate social responsibility on organizational performance in the Iranian pharmaceutical industry: The mediating role of TQM. Journal of Cleaner Production. 135, 689-698. https://doi.org/10.1016/j.jclepro.2016.06.116

Mögele, B., & Tropp, J. (2010). The emergence of CSR as an advertising topic: A longitudinal study of German CSR advertisements. Journal of Marketing Communications, 16(3), 163-181. https://doi.org/10.1080/13527260802648359

Min, M., Desmoulins-Lebeault, F., & Esposito, M. (2017). Should pharmaceutical companies engage in corporate social responsibility? Journal of Management Development, 36(1), 58-70. https://doi.org/10.1108/JMD-09-2014-0103

Nussbaum, A. (2009). Ethical corporate social responsibility (CSR) and the pharmaceutical industry: A happy couple? Journal of Medical Marketing, 9(1), 67-76. https://doi.org/10.1057/jmm.2008.33

O’Riordan, L., & Fairbrass, J. (2008). Corporate social responsibility (CSR): Models and theories in stakeholder dialogue. Journal of Business Ethics, 83(4), 745-758. https://doi.org/10.1007/s10551-008-9662-y

Osterath, B. (2014, March 23). The drug divide: Concerns grow in the US over generics produced in India. DW. https://www.dw.com/en/the-drug-divide-concerns-grow-in-the-us-over-generics-produced-in-india/a-17507784

Palazzo, G., & Scherer, A. (2006). Corporate legitimacy as deliberation: A communicative framework. Journal of Business Ethics, 66(1),71-88. https://doi.org/10.1007/s10551-006-9044-2

Pisano, G. (2006). Science business: The promise, the reality, and the future of biotech (1st ed.). Harvard Business Press.

Price Water House Coopers (2009). Pharma 2020: Challenging business models. Which path will you take? https://www.pwc.com/gx/en/pharma-life-sciences/pdf/challenge.pdf

Rodríguez, P., Siegel, D. S., Hillman, A., & Eden, L. (2006). Three lenses on the multinational enterprise: Politics, corruption, and corporate social responsibility. Journal of International Business Studies, 37(6), 733-746. https://doi.org/10.1057/palgrave.jibs.8400229

Rusu, A., Kuokkanen, K., & Heier, A. (2011). Current trends in the pharmaceutical industry – A case study approach. European Journal of Pharmaceutical Sciences44(3), 437–440. https://doi.org/10.1016/j.ejps.2011.07.008

Shamir, R. (2008). The age of responsibilization: On market-embedded morality. Economy and Society, 37(1), 1-19. https://doi.org/10.1080/03085140701760833

Sillup, G., Makowska, M., & Porth, S. (2017). Ethical issues affecting the pharmaceutical industry-a comparison of newspaper coverage in the U.S. and Poland. Acta Poloniae Pharmaceutica - Drug Research, 74(4), 1301-1312. https://www.academia.edu/download/53858784/1301.pdf

Strand, R., Freeman, R. E., & Hockerts, K. (2015). Corporate social responsibility and sustainability in Scandinavia: An overview. Journal of Business Ethics, 127(1), 1-15. http://doi.org/10.1007/s10551-014-2224-6

Suchanek, A., & Lin-Hi, N. (2007). Corporate responsibility in the research-based pharmaceutical industry. Jahrbucher Fur Nationalokonomie Und Statistik, 227(5-6), 547-562. http://doi.org/10.1515/jbnst-2007-5-609

Thorsteinsdóttir, H., Ovtcharenko, N., & Kohler, J. C. (2017). Corporate social responsibility to improve access to medicines: the case of Brazil. Globalization and Health 13(10), 1-12. http://doi.org/10.1186/s12992-017-0235-7

Vanhamme, J., & Grobben, B. (2009). Too good to be true! The effectiveness of CSR history in countering negative publicity. Journal of Business Ethics, 85(2), 273–83. https://doi.org/10.1007/s10551-008-9731-2

World Commission on Environment and Development (WCED) (1987). Our common future. The Brundtland Report. United Nations, General Assembly. https://web.archive.org/web/20111201061947/ http://worldinbalance.net/pdf/1987-brundtland.pdf

World Health Organization (2012). Why is good governance relevant to the pharmaceutical public sector? http://www.who.int/medicines/areas/policy/goodgovernance/why/en/

Zhao, H., Zhangb, F., & Kwonc, J. (2017). Corporate social responsibility research in international business journals: An author co-citation analysis. International Business Review, 27(2), 389-400. http://doi.org/10.1016/j.ibusrev.2017.09.006